0 CHECKOUT

PRODUCT FILTERS

REGION

43
14
8
8
1

COUNTRY

14
1

CATEGORIES

  • 99
  • 32
  • 32
  • 28
  • 17
  • 8
  • 7
  • 7
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

74
109
165
222

PUBLISHED

1
19
60
222

PRODUCT TYPE

84
78
35
19
2
2
1
1

Search for: "Disease and Therapy Review: Multiple Sclerosis"

Multiple sclerosis - Market Insights, Epidemiology and Market Forecast-2020

Multiple sclerosis - Market Insights, Epidemiology and Market Forecast-2020 Reports provides an overview of the disease and global market trends for the seven major markets ie: United States, EU5 (France,...

Published:  April 2016
Price:  From

Multiple Sclerosis - Pipeline Review, H1 2015

Multiple Sclerosis - Pipeline Review, H1 2015 Summary the, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015 Summary The report ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015 Summary The report ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015’, provides an overview of the Relapsing Multiple Sclerosis...

Published:  November 2015
Price:  From

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015 Summary The report ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2015’, provides an overview of the...

Published:  September 2015
Price:  From

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015 Summary This, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H1 2015’, provides an overview of the Primary...

Published:  March 2015
Price:  From

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency...

Published:  July 2013
Price:  From

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015 Summary This, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing...

Published:  May 2015
Price:  From

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015 Summary The report ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015’, provides an overview of the...

Published:  November 2015
Price:  From

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015 Summary This, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015’, provides an overview of the Secondary...

Published:  January 2015
Price:  From

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015 Summary The report ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2015’, provides an overview of...

Published:  July 2015
Price:  From

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015 Summary This, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing Multiple Sclerosis...

Published:  April 2015
Price:  From

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update Summary Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized...

Published:  April 2013
Price:  From

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

Published:  June 2016
Price:  From

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Multiple Sclerosis Therapeutics...

Published:  February 2012
Price:  From

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016 Summary ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline...

Published:  February 2016
Price:  From

Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tysabri (Multiple Sclerosis) - Forecast and Market...

Published:  March 2013
Price:  From

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015 Summary The report ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s...

Published:  September 2015
Price:  From

Autoimmune Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns...

Published:  October 2011
Price:  From

BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022

BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “BG-12 (Multiple Sclerosis) - Forecast and Market Analysis...

Published:  March 2013
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Electronics Co., Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.